Esperion Therapeutics Inc Extraordinary Shareholders Meeting Transcript
Good morning, and welcome to the special meeting of the stockholders of Esperion's Therapeutics. I am J. Martin Carroll, Chairperson of the Board of Directors of Esperion Therapeutics, and I'm joined by Benjamin Looker, Chief Legal and Corporate Affairs Officer of Esperion Therapeutics and Secretary for this special meeting.
I welcome you to our special meeting of stockholders. The meeting will be conducted in accordance with the rules of conduct that are posted to the web portal. It is now 8:00 AM. And this meeting is officially called to order. The business before this meeting is described in the proxy statement, which was first made available on or about June 8, 2026.
I present to this meeting copies of the notice of special meeting of the stockholders and the Proxy Statement, which were mailed to our common stockholders of record as of the close of business on May 28, 2026, the record date for this meeting. With such mailing commencing on June 8, 2026, together with an affidavit. As to such mailing, all
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
